1592U89

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2002
02419962002

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
While in vitro results at clinically relevant concentrations do not predict abacavir (1592U89) interactions with drugs highly… (More)
Is this relevant?
2000
2000
Abacavir (1592U89) is a nucleoside inhibitor of human immunodeficiency virus (HIV) type 1 reverse transcriptase (RT). Resistance… (More)
Is this relevant?
2000
2000
Abacavir (formerly 1592U89) is a carbocyclic nucleoside analog with potent anti-human immunodeficiency virus (anti-HIV) activity… (More)
Is this relevant?
1999
1999
Abacavir (formerly 1592U89) is a potent 2'-deoxyguanosine analog reverse transcriptase inhibitor that has been demonstrated to… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
1999
1999
Abacavir (1592U89), a nucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type… (More)
Is this relevant?
1999
1999
Abacavir (1592U89) is a nucleoside analog reverse transcriptase inhibitor that has been demonstrated to have selective activity… (More)
Is this relevant?
1998
1998
The use of combinations of anti-human immunodeficiency virus (anti-HIV) agents targeted to different molecular targets will most… (More)
Is this relevant?
1997
1997
1592U89, (-)-(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclo pentene-1-methanol, is a carbocyclic nucleoside with… (More)
Is this relevant?
1997
1997
The anabolism of 1592U89, (-)-(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclo pentene-1-methanol, a selective… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
1997
1997
The carbocyclic nucleoside 1592U89 is a selective inhibitor of the human immunodeficiency virus (HIV), targeting the reverse… (More)
Is this relevant?